By vgreene, 17 December, 2014 If HT not OK by 10-yr CVD risk,3 menopause duration, breast CA/other risks:7,8
By vgreene, 16 December, 2014 Decision about HT duration:<sup>4</sup> continued mod-to-severe sx, pt preference, risks for breast CA/CVD/osteoporosis, etc<sup>3,7,10</sup>
By vgreene, 16 December, 2014 If uterus intact:<sup>9</sup> E+P options (CE+bazedoxifene may also be an option)
By vgreene, 16 December, 2014 If HT OK by 10-yr CVD risk3 and menopause duration, consider individual breast CA risk7 and HT contraindications:8
By vgreene, 16 December, 2014 Guideline & mobile app for menopausal sx mgmnt & hormonal/nonhormonal therapy decision making from NAMS. <i>Menopause: The Journal of The North American Menopause Society.</i> Vol. 22, No. 3, pp. 000/000.